James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), bought 3,358 shares at $59.33 ($199K) on 2018-11-16, disclosed to the SEC on 2018-11-19.
Open-market purchase of $199k RETA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.33 | 1,679 | $100K | 50.0% |
| 2 | $59.33 | 1,679 | $100K | 50.0% |
| Total | $59.33 avg | 3,358 | $199K | 100% |
| Filing → |
| RETA | BUY | 2018-07-26 | $139K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |
| RETA | BUY | 2017-08-01 | $250K | — | Filing → |